CD47/IAP Modulation of Immune Cell Functions
CD47/IAP Modulation of Immune Cell Functions
批准号:
6917763
负责人:
WILLIAM A FRAZIER
金额:
$5.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 2007-04-30
关键词:
CD47 moleculeapoptosiscell migrationclinical researchflow cytometrygene rearrangementgene targetinggenetically modified animalshuman tissueimmunityimmunocytochemistryimmunoglobulin Gimmunoglobulin Mimmunoglobulin genesinflammationintegrinslaboratory mouseleukocyte activation /transformationneutrophilphagocytosisprotein bindingprotein kinase Areceptor bindingterminal nick end labelingtransmission electron microscopywestern blottings
中文摘要
描述(由申请人提供):在本资助第一个周期的工作中,我们意识到CD47或整合素相关蛋白可以通过直接激活异三聚体Gi来调节许多血管整合素的功能。人们对CD47在免疫系统中的功能知之甚少。我们发现CD47及其对抗受体SIRPalpha构成了一种新的自我识别系统,可以阻止携带CD47的循环细胞的吞噬。这个系统的失败会导致自身免疫综合征。CD47(血小板反应蛋白)、单克隆抗体和SIRPalpha的所有配体都可以在活化淋巴细胞中诱导一种新的细胞死亡形式,即Jurkats和抗cd3活化的正常T细胞。其机制涉及异三聚体G蛋白和PKA活性的衰减,导致δ -psi-m的丢失。我们发现CD47缺失小鼠在IgM到IgG类转换方面存在严重缺陷。在这里,我们建议研究CD47在免疫系统中这些新发现的功能背后的机制。目标是:1。确定CD47-SIRPalpha抑制循环细胞吞噬的生物学作用和机制。这通常会减弱自身抗原的呈现,其机制提示了一种治疗自身免疫性溶血性贫血的新方法。2. 研究CD47介导细胞死亡的机制,特别是G蛋白与线粒体损伤的联系。3. 利用CD47缺失小鼠来确定CD47在免疫细胞发育、免疫反应中的类转换和自身免疫中的作用。
英文摘要
DESCRIPTION (provided by applicant): As a result of work during the first cycle of this grant, we realize that CD47 or integrin-associated protein can modulate the function of a number of vascular integrins through its direct activation of heterotrimeric Gi. Much less is known about CD47 function in the immune system. We have found that CD47 and its counter receptor SIRPalpha constitute a novel recognition of self system that prevents phagocytosis of CD47-bearing circulating cells. Failure of this system leads to autoimmune syndromes. All ligands of CD47 (thrombospondin, monoclonal antibodies and SIRPalpha can induce a novel form of cell death in activated lymphocytes, i.e., Jurkats and anti-CD3 activated normal T cells. The mechanism involves heterotrimeric G proteins and attenuation of PKA activity leading to a loss of delta-psi-m. We find that CD47 null mice have a severe defect in IgM to IgG class switching. Here we propose to investigate the mechanisms behind these newly revealed functions of CD47 in the immune system. The aims are: 1. Determine the biological role and mechanism of the CD47-SIRPalpha inhibition of phagocytosis of circulating cells. This normally attenuates presentation of self antigens and its mechanism suggests a novel treatment for autoimmune hemolytic anemia. 2. Investigate the mechanism of CD47 mediated cell death, particularly the connection from G proteins to mitochondrial damage. 3. Use CD47 null mice to define the role of CD47 in development of immune cells, in class switching during an immune response and in autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor-toxic CD47 mAb therapy for leukemia: a proof of concept study
-
批准号:8520948
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2013
-
负责人:WILLIAM A FRAZIER
-
依托单位:
Development of a humanized anti-CD47 antibody for treatment of tissue ischemia.
-
批准号:7669899
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2009
-
负责人:WILLIAM A FRAZIER
-
依托单位:
Integrin Associated Protein in a Thrombospondin Receptor
-
批准号:6752865
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
Integrin Associated Protein in a Thrombospondin Receptor
-
批准号:7418842
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
-
批准号:7622611
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
-
批准号:7370079
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
-
批准号:7883168
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
Integrin Associated Protein in a Thrombospondin Receptor
-
批准号:6901007
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
-
批准号:8100483
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
-
批准号:8288113
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
Integrin Associated Protein in a Thrombospondin Receptor
-
批准号:6547705
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
Integrin Associated Protein in a Thrombospondin Receptor
-
批准号:6607273
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:WILLIAM A FRAZIER
-
依托单位:
CD47/IAP Modulation of Immune Cell Functions
-
批准号:6743725
-
项目类别:
-
资助金额:$29.9万
-
财政年份:1998
-
负责人:WILLIAM A FRAZIER
-
依托单位:
CD47/IAP Modulation of Immune Cell Functions
-
批准号:6613293
-
项目类别:
-
资助金额:$31.02万
-
财政年份:1998
-
负责人:WILLIAM A FRAZIER
-
依托单位:
CD47/IAP Modulation of Immune Cell Functions
-
批准号:6888494
-
项目类别:
-
资助金额:$31.05万
-
财政年份:1998
-
负责人:WILLIAM A FRAZIER
-
依托单位:
CD47/IAP Modulation of Immune Cell Functions
-
批准号:7056817
-
项目类别:
-
资助金额:$29.2万
-
财政年份:1998
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN IS A THROMBOSPONDIN RECEPTOR
-
批准号:2900885
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1997
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN IS A THROMBOSPONDIN RECEPTOR
-
批准号:2685112
-
项目类别:
-
资助金额:$19.44万
-
财政年份:1997
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN IS A THROMBOSPONDIN RECEPTOR
-
批准号:2023399
-
项目类别:
-
资助金额:$19.02万
-
财政年份:1997
-
负责人:WILLIAM A FRAZIER
-
依托单位:
INTEGRIN ASSOCIATED PROTEIN IS A THROMBOSPONDIN RECEPTOR
-
批准号:6181287
-
项目类别:
-
资助金额:$20.59万
-
财政年份:1997
-
负责人:WILLIAM A FRAZIER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: